retatrutide ozempic vs Doctor Comment: Eli Lilly Drug

Most side effects peak during dose escalation and improve at maintenance dose

This is because the medicine is still being tested

Research suggests GIP activation improves insulin sensitivity in adipose tissue, may contribute to central nervous system appetite regulation beyond what GLP-1 provides, and appears to reduce some of the gastrointestinal side effects associated with GLP-1 agonism alone

The situation is improving a little for Wegovy patients but 83% of patients with coverage still face barriers, including the Byzantine processes involved in securing prior authorizations and documenting compliance with step therapy requirements